NCT06168266

Brief Summary

The goal of this study is to design eccentric exercise strategies for COPD patients to comprehensively improve their cardiopulmonary/muscular fitness, immune and hemorheological functions, and quality of life, thereby improving the prognosis of their disease.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
20mo left

Started Dec 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress59%
Dec 2023Dec 2027

First Submitted

Initial submission to the registry

December 5, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 13, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

December 13, 2023

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

February 12, 2026

Status Verified

February 1, 2026

Enrollment Period

3.9 years

First QC Date

December 5, 2023

Last Update Submit

February 10, 2026

Conditions

Keywords

COPDEccentric Exercise TrainingLymphocytesMitochondriaErythrocytesRheology

Outcome Measures

Primary Outcomes (1)

  • cardiopulmonary oxygen consumption

    to observe the maximum exercise performance

    12 weeks

Study Arms (2)

Control group

ACTIVE COMPARATOR

Undergoing conventional treatment

Other: conventional group

Intervention Group: eccentric cycling exercise

EXPERIMENTAL

Received eccentric cycling exercise

Device: Eccentric bike

Interventions

Received eccentric cycling exercise

Intervention Group: eccentric cycling exercise

Received conventional treatment

Control group

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having undergone pulmonary rehabilitation for more than 3 months
  • Sign the written informed consent form
  • FEV1/FVC \< 0.70
  • Approval for exercise training granted by a specialist physician's assessment
  • Specialist physician's approval for exercise training

You may not qualify if:

  • Existing of tracheostomy
  • Those who use oxygen therapy or ventilator at home
  • Severe heart failure (NYHA III-IV)
  • Neuromuscular disease
  • Acute exacerbation within the past three months
  • Those who are unable to cooperate with the cardiopulmonary exercise test
  • Taking anticoagulant medications
  • Other conditions restricting exercise for over a year
  • Recent or planned significant cardiovascular surgery or intervention
  • Current or planned pregnancy within the next year
  • Planned heart transplant within the next six months
  • Heart failure due to uncorrectable valvular heart disease, congenital heart disease or obstructive cardiomyopathy
  • Inadequate ICD settings for exercise heart rate
  • Other exercise contraindications: unstable angina, uncontrolled blood pressure, orthostatic hypotension with symptoms, severe aortic stenosis, acute discomfort or fever, uncontrolled arrhythmias, uncompensated heart failure, acute pericarditis or myocarditis, recent thrombosis or thrombophlebitis, resting ST-segment deviation, uncontrolled diabetes, etc.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fu Jen Catholic University Hospital, Fu Jen Catholic University

New Taipei City, 24352, Taiwan

RECRUITING

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Ke-Yun Chao, PhD

    Fu Jen Catholic University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Group leader of Respiratory Therapists

Study Record Dates

First Submitted

December 5, 2023

First Posted

December 13, 2023

Study Start

December 13, 2023

Primary Completion (Estimated)

October 30, 2027

Study Completion (Estimated)

December 30, 2027

Last Updated

February 12, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations